Celcuity (CELC): צמיחת הכנסות מרבעון לרבעון

CELC (celcuity.com) - סמל מסחרי של החברה

Celcuity Inc. (CELC) is creating an environment for personalized therapy selection, although the automation of cellular analysis is currently being implemented only selectively. Quarterly revenue changes resolve this dissonance, demonstrating that the latest parameter is 0.00. This trend is critical, as a chronic lack of profitability and fierce competition in cancer diagnostics create significant financial risks for the business.

CELC (Celcuity Inc) היסטוריית צמיחת מכירות רבעונית מ-04.07.2022 עד 20.11.2026

Celcuity - פילוחים אנליטיים ומדדי מפתח (CELC)

- מחיר מניה ומחיר יעד קונצנזוס:
- נתוני שווי שוק בבורסה:
ניתוח ראשוני של החברה:Celcuity Therapeutics - CELC
מוצר סדרתי של celcuity.com

For Celcuity Inc., which is scaling its live-cell analysis platform in oncology diagnostics, the quarter-over-quarter revenue growth rate serves as an indicator of the commercialization of its unique tumor activity measurement method. This metric compares current sales with the previous quarter, allowing investors to assess the speed of business expansion and determine the transition point from aggressive market capture to a stage of stable operational maturity.